发明名称 Pharmaceutical formulations of desmopressin
摘要 Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
申请公布号 US9504647(B2) 申请公布日期 2016.11.29
申请号 US201514947261 申请日期 2015.11.20
申请人 FERRING B.V. 发明人 Nilsson Anders;Lindner Hans;Wittendorff Jørgen
分类号 A61K9/20;A61K9/46;A61K38/08;A61K9/00;A61K38/11;A61K38/12;A61K47/42 主分类号 A61K9/20
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP
主权项 1. A solid orodispersible pharmaceutical dosage form of desmopressin acetate, comprising desmopressin acetate in an open matrix network carrying the desmopressin acetate, wherein the open matrix network comprises a water-soluble or water-dispersible carrier material inert to the desmopressin acetate that comprises gelatin, and wherein the dosage form disintegrates in the mouth within 10 seconds.
地址 Hoofddorp NL